Literature DB >> 10417628

FGF expression allows nevus cells to survive in three-dimensional collagen gel under conditions that induce apoptosis in normal human melanocytes.

T Alanko1, M Rosenberg, O Saksela.   

Abstract

Melanocytes, the pigment forming cells of the skin, form an almost nonproliferating cell population located to the lowermost part of the epidermis. Normally melanocytes are not found higher in the epidermis or in the dermis. Nevi consist of melanocytes with altered growth characteristics and localization. The common pigmented nevus, a benign skin lesion, develops when melanocytes proliferate in the dermo-epidermal junction or in the dermis. Here we report growth characteristics of in vitro cultured normal human melanocytes and dermal nevus-derived melanocytes. As previously reported, nevus cells have a moderate to high FGF-2 expression level. Here we demonstrate that dermal nevus cells are able to survive in three-dimensional type 1 collagen culture, while normal human melanocytes rapidly undergo apoptosis. Melanocytes also, however, survive in collagen cultures in the presence of exogenous FGF-2. The survival of nevus cells in collagen is suppressed by protamine, an inhibitor of FGF-mediated cell stimulation. The in vivo growth environment of dermal nevus cells consists largely of type I and type III collagens. The results suggest that FGF-2 expression by nevus cells allows them to adapt to grow in the dermis. FGF-2 obviously has importance as a melanocyte survival factor and probably also in the development of malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417628     DOI: 10.1046/j.1523-1747.1999.00636.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  10 in total

1.  Activation of dual apoptotic pathways in human melanocytes and protection by survivin.

Authors:  Tong Liu; Diana Biddle; Adrianne N Hanks; Brook Brouha; Hui Yan; Ray M Lee; Sancy A Leachman; Douglas Grossman
Journal:  J Invest Dermatol       Date:  2006-05-25       Impact factor: 8.551

2.  Metastatic outgrowth encompasses COL-I, FN1, and POSTN up-regulation and assembly to fibrillar networks regulating cell adhesion, migration, and growth.

Authors:  Johanna Soikkeli; Piotr Podlasz; Miao Yin; Pirjo Nummela; Tiina Jahkola; Susanna Virolainen; Leena Krogerus; Päivi Heikkilä; Karl von Smitten; Olli Saksela; Erkki Hölttä
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

3.  The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management.

Authors:  Keith Duffy; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2012-07       Impact factor: 11.527

4.  Proliferation, apoptosis, and survivin expression in a spectrum of melanocytic nevi.

Authors:  Scott R Florell; Anneli R Bowen; Adrianne N Hanks; Kelley J Murphy; Douglas Grossman
Journal:  J Cutan Pathol       Date:  2005-01       Impact factor: 1.587

Review 5.  Nanoparticle-mediated drug delivery for treating melanoma.

Authors:  Vaibhav Mundra; Wei Li; Ram I Mahato
Journal:  Nanomedicine (Lond)       Date:  2015-08-05       Impact factor: 5.307

6.  MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation.

Authors:  Svenja Meierjohann; Anita Hufnagel; Elisabeth Wende; Markus A Kleinschmidt; Katarina Wolf; Peter Friedl; Stefan Gaubatz; Manfred Schartl
Journal:  Mol Cancer       Date:  2010-07-28       Impact factor: 27.401

7.  Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.

Authors:  Johanna Eriksson; Vadim Le Joncour; Pirjo Nummela; Tiina Jahkola; Susanna Virolainen; Pirjo Laakkonen; Olli Saksela; Erkki Hölttä
Journal:  Oncotarget       Date:  2016-03-22

Review 8.  Fibroblast Growth Factor Receptor Signaling in Skin Cancers.

Authors:  Malgorzata Czyz
Journal:  Cells       Date:  2019-06-04       Impact factor: 6.600

9.  Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas, and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls.

Authors:  Johanna Eriksson; Vadim Le Joncour; Tiina Jahkola; Susanna Juteau; Pirjo Laakkonen; Olli Saksela; Erkki Hölttä
Journal:  Mol Oncol       Date:  2020-02-28       Impact factor: 6.603

10.  Divergent roles of lysyl oxidase family members in ornithine decarboxylase- and RAS-transformed mouse fibroblasts and human melanoma cells.

Authors:  Mari Kielosto; Johanna Eriksson; Pirjo Nummela; Miao Yin; Erkki Hölttä
Journal:  Oncotarget       Date:  2018-12-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.